Clinical Trials Browser

OTHER × Esophagogastric Cancer × zirconium-89-trastuzumab × Clear all

NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Phase NA Completed

42 enrolled 11 charts

Gastrointestinal

Esophagogastric Cancer